Cantor Fitzgerald initiated coverage of Eli Lilly (LLY) with an Overweight rating and $975 price target Published first on ...

Cantor Fitzgerald analyst Carter Gould downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down ...

Cantor Fitzgerald trimmed its price target on Intel (NASDAQ:INTC) to $20 from $29 while maintaining a Neutral rating, ...

President Trump is relying on a cast of economic advisers with differing viewpoints and backgrounds as he implements a ...

Cantor Fitzgerald analyst C J Muse reiterated a Buy rating on Nvidia (NVDA – Research Report) yesterday and set a price target of $200.00.Stay ...

Cantor Fitzgerald lowered the firm’s price target on Meta Platforms (META) to $624 from $790 and keeps an Overweight rating on the shares. The ...

Troubling links tie tech money to both Greenland and Trump. The tech industry desperately needs the rare earth minerals on ...

President Trump’s former White House chief strategist said the commerce secretary should stop doing media appearances.

Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...

Steve Bannon has come out against one Trump cabinet member, calling him 'close to an unmitigated disaster' and he's blaming ...